Plasma composition in the nephrotic syndrome
- PMID: 8116687
- DOI: 10.1159/000168649
Plasma composition in the nephrotic syndrome
Abstract
The nephrotic syndrome is a consequence of urinary loss of intermediate sized plasma proteins and the resulting homeostatic responses to those losses. Plasma protein composition is changed greatly. Intermediate sized proteins, including albumin, transferrin, IgG, hormone binding proteins, and low molecular weight inhibitors of the clotting cascade, are lost in the urine and their concentration in plasma reduced. Synthesis of many proteins secreted by the liver is increased either at the level of transcription or posttranscriptionally. Synthesis of several liver-derived proteins is increased in the absence of their urinary loss, suggesting that hypoalbuminemia or reduced plasma oncotic pressure (tau) stimulates the production or reduces the rate of catabolism of these proteins. Their plasma levels, including those of lipoproteins and elements of the coagulation cascade, are increased. Plasma tau falls and plasma viscosity increases because of the replacement of intermediate sized plasma proteins by larger ones. The plasma concentration of several proteins lost in the urine but not secreted by the liver, such as erythropoietin and IgG, are not defended by increased synthesis, suggesting that increased synthesis of plasma proteins is primarily confined to the liver. Loss of both liver-derived and non-liver-derived proteins may cause reduced immunity, anemia, and deficiency syndromes. Urinary loss of albumin alone is not responsible for decreased plasma pi. The relationship between plasma protein concentration and pi is greatly disturbed in nephrotic rats. In contrast, the relationship between pi and plasma protein concentration is nearly the same in rats with hereditary analbuminemia (NAR) and normal rats, despite the absence of albumin from the plasma of NAR. When proteinuria is induced in NAR the relationship between plasma protein concentration and pi becomes identical to that in nephrotic animals, although no albumin was lost in the urine of NAR.
Similar articles
-
Nonrenal complications of the nephrotic syndrome.Annu Rev Med. 1994;45:201-10. doi: 10.1146/annurev.med.45.1.201. Annu Rev Med. 1994. PMID: 8198377 Review.
-
Plasma IgG pool is not defended from urinary loss in nephrotic syndrome.Am J Physiol. 1992 Mar;262(3 Pt 2):F333-7. doi: 10.1152/ajprenal.1992.262.3.F333. Am J Physiol. 1992. PMID: 1558152
-
Coordinate augmentation in expression of genes encoding transcription factors and liver secretory proteins in hypo-oncotic states.Kidney Int. 1999 Aug;56(2):452-60. doi: 10.1046/j.1523-1755.1999.00562.x. Kidney Int. 1999. PMID: 10432383
-
Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis.Am J Physiol. 1992 May;262(5 Pt 2):F755-61. doi: 10.1152/ajprenal.1992.262.5.F755. Am J Physiol. 1992. PMID: 1590420
-
Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.Miner Electrolyte Metab. 1992;18(2-5):212-6. Miner Electrolyte Metab. 1992. PMID: 1465061 Review.
Cited by
-
A pharmacokinetic model for the glycation of albumin.J Pharmacokinet Pharmacodyn. 2012 Jun;39(3):273-82. doi: 10.1007/s10928-012-9249-1. Epub 2012 Apr 21. J Pharmacokinet Pharmacodyn. 2012. PMID: 22528035
-
The novel diagnostic biomarkers for focal segmental glomerulosclerosis.Int J Nephrol. 2014;2014:574261. doi: 10.1155/2014/574261. Epub 2014 Mar 26. Int J Nephrol. 2014. PMID: 24790760 Free PMC article.
-
A novel differential diagnostic model based on multiple biological parameters for immunoglobulin A nephropathy.BMC Med Inform Decis Mak. 2012 Jun 27;12:58. doi: 10.1186/1472-6947-12-58. BMC Med Inform Decis Mak. 2012. PMID: 22738421 Free PMC article.
-
Off-label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics.Br J Clin Pharmacol. 2020 Feb;86(2):274-284. doi: 10.1111/bcp.14174. Epub 2020 Jan 14. Br J Clin Pharmacol. 2020. PMID: 31725919 Free PMC article. Review.
-
Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.Br J Clin Pharmacol. 2010 Apr;69(4):358-66. doi: 10.1111/j.1365-2125.2010.03615.x. Br J Clin Pharmacol. 2010. PMID: 20406220 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
